Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06445504 · ClinicalTrials.gov registry record · NA
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
A NA study of Ventral Hernia and Inguinal Hernia, sponsored by Medtronic - MITG.
- Active
- Registry status
- NA
- Development phase
- 193
- Enrollment target
- 7
- Study locations
NCT06445504: Active NA study of Ventral Hernia and Inguinal Hernia, sponsored by Medtronic - MITG.
NCT06445504 is a NA study of Ventral Hernia and Inguinal Hernia that is active but no longer recruiting, run by Medtronic - MITG. The registered enrollment target is 193 participants, above the 132-participant average among 18 other Ventral Hernia trials with a reported enrollment target (46% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06445504, a NA study of Ventral Hernia and Inguinal Hernia, is active but no longer recruiting, sponsored by Medtronic - MITG.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
- 7
- Study locations
Study Summary
A prospective, multicenter, single-arm pivotal study will be performed with 192 subjects enrolled to have an inguinal or ventral robotic hernia repair procedure using the Medtronic Hugo™ RAS system. Subjects will be followed through two years. This study will be conducted using up to ten investigative sites in the United States (US).
Primary Outcome
The primary effectiveness endpoint is rate of subjects who have surgical success, with surgical success defined as the procedure not going into conversion. Conversion is defined as the switch from the robotic-assisted approach using the Hugo™ RAS system to laparoscopic, open surgery, or use of an alternative robotic-assisted system.
Conditions Studied
Interventions
- DEVICE Robotic-Assisted Surgery (RAS) Hernia Repair Surgery
Study Locations (7)
Florida
- Tampa General Hospital - Tampa
Illinois
- University of Illinois, Chicago - Chicago
New York
- University of Buffalo - Buffalo
North Carolina
- Duke University - Durham
Ohio
- Cleveland Clinic - Cleveland
Texas
- UT Health - Houston
Virginia
- Bon Secours - Newport News
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2024-04-08 |
| Est. Completion | 2027-03-15 |
| Phase | NA |
What the registry record for NCT06445504 still lists
NCT06445504 is an interventional study that assigns participants to a tested intervention. The registered 193 participants enrollment target is mid-sized for trials with a published cap, above the 132-participant average among 18 other Ventral Hernia trials with a reported enrollment target (46% higher).
The record links to 2 conditions, with Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which Robotic-Assisted Surgery (RAS) Hernia Repair Surgery is the first listed.
NCT06445504 lists 7 locations in 7 states (Florida, Illinois, New York).
Frequently Asked Questions
What is clinical trial NCT06445504 about?
NCT06445504 is a clinical study titled "Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)". A prospective, multicenter, single-arm pivotal study will be performed with 192 subjects enrolled to have an inguinal or ventral robotic hernia repair procedure using the Medtronic Hugo™ RAS system. Subjects will be followed through two years. This study will be conducted using up to ten investigati...
What is the current status of trial NCT06445504?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 193 participants. The study started on 2024-04-08. Estimated completion is 2027-03-15.
What conditions does trial NCT06445504 study?
This clinical trial studies the following conditions: Ventral Hernia, Inguinal Hernia.
What interventions are being tested in trial NCT06445504?
The interventions under investigation include: Robotic-Assisted Surgery (RAS) Hernia Repair Surgery (DEVICE).
Who is sponsoring clinical trial NCT06445504?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06445504 being conducted?
This trial has 7 study locations across Florida, Illinois, New York, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06445504's enrollment target sits among peer trials
193 6th of 18 higher than 13 of 18 other Ventral Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
ACTIVE NOT RECRUITING · NA
-
CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs
ACTIVE NOT RECRUITING · NA
-
Mesh Type in Ventral Hernia Repair
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06226220 · 193 participants · NA
Percutaneous Nerve Evaluation Trial Time
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI